Evidence map›Paper›PMID 20026221›Full record

ArticleNeuroImage2010

The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults.

Stefan Ehrlich, Eric M Morrow, Joshua L Roffman, Stuart R Wallace, Melissa Naylor, H Jeremy Bockholt, Antonia Lundquist, Anastasia Yendiki, Beng-Choon Ho, Tonya White and 5 more

Open access · greenAbstract read
In one paragraph

Article in NeuroImage, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Neuropsychiatric disease and treatment · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Stefan EhrlichMGH/MIT/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA 02129-2000, USA. stefan@nmr.mgh.harvard.edu
Eric M Morrow
Joshua L Roffman
Stuart R Wallace
Melissa Naylor
H Jeremy Bockholt
Antonia Lundquist
Anastasia Yendiki
Beng-Choon Ho
Tonya White
Dara S Manoach
Vincent P Clark
Vince D Calhoun
Randy L Gollub
Daphne J Holt
Athinoula A. Martinos Center for Biomedical Imaging · USMind Research Network · USMassachusetts General Hospital · USBrown University · USHarvard University · USUniversity of Iowa · USUniversity of Minnesota · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
ZD6416 Analgesic--Painful Distal Symmetrical PolyneuropaM01RR001066 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, EMERY N · 1985 to 2008
$37.4M
FUNCTION BIRNU24RR021992 · NCRR · UNIVERSITY OF CALIFORNIA-IRVINE · PI POTKIN, STEVEN G · 2006 to 2010
$25.0M
MORPHOMETRY BIOMEDICAL INFORMATICS RESEARCH NETWORKU24RR021382 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2004 to 2008
$24.1M
ULTRAHIGH FIELD TECHNOLOGY FOR FUNCTIONAL IMAGINGP41RR014075 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 1999 to 2011
$16.4M
The Neural Basis of Delusions in Schizophrenia: Studies of Emotional PerceptionK23MH076054 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HOLT, DAPHNE J · 2006 to 2010
$968k
Genetic investigation of cognitive development in autistic spectrum disorders.K23MH080954 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI MORROW, ERIC M · 2007 to 2011
$920k
NCRR NIH HHS 1U24 RR021382ANCRR NIH HHS M01 RR001066NCRR NIH HHS M01-RR-01066NCRR NIH HHS P41 RR014075NCRR NIH HHS P41RR14075NCRR NIH HHS U24 RR021382NCRR NIH HHS U24 RR021992NCRR NIH HHS U24RR021992NCRR NIH HHS UL1 RR025758NIMH NIH HHS K23 MH076054NIMH NIH HHS K23MH076054NIMH NIH HHS K23 MH080954
6 · The paper itself

Abstract

Abnormalities of the medial temporal lobe have been consistently demonstrated in schizophrenia. A common functional polymorphism, Val108/158Met, in the putative schizophrenia susceptibility gene, catechol-O-methyltransferase (COMT), has been shown to influence medial temporal lobe function. However, the effects of this polymorphism on volumes of medial temporal lobe structures, particularly in patients with schizophrenia, are less clear. Here we measured the effects of COMT Val108/158Met genotype on the volume of two regions within the medial temporal lobe, the amygdala and hippocampus, in patients with schizophrenia and healthy control subjects. We obtained MRI and genotype data for 98 schizophrenic patients and 114 matched controls. An automated atlas-based segmentation algorithm was used to generate volumetric measures of the amygdala and hippocampus. Regression analyses included COMT met allele load as an additive effect, and also controlled for age, intracranial volume, gender and acquisition site. Across patients and controls, each copy of the COMT met allele was associated on average with a 2.6% increase in right amygdala volume, a 3.8% increase in left amygdala volume and a 2.2% increase in right hippocampus volume. There were no effects of COMT genotype on volumes of the whole brain and prefrontal regions. Thus, the COMT Val108/158Met polymorphism was shown to influence medial temporal lobe volumes in a linear-additive manner, mirroring its effect on dopamine catabolism. Taken together with previous work, our data support a model in which lower COMT activity, and a resulting elevation in extracellular dopamine levels, stimulates growth of medial temporal lobe structures.

Indexed as

Brain MappingGenetic Predisposition to DiseaseAlgorithmsCatechol O-MethyltransferaseGenotypeHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingPolymorphism, Single NucleotideSchizophreniaTemporal LobeCatechol O-Methyltransferase

Identifiers

PMID20026221
PMCPMC2888809
OpenAlexW2006653614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.